GlassScriptPhysician profile
Gary Wayne Yawn
NPI 1013179860
$29,191.82
in general payments reported to CMS, 2019-2025
44 companies · $5,497 in 2025
The $5,497 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,769 · 2020: $1,488 · 2021: $3,159 · 2022: $2,935 · 2023: $4,130 · 2024: $10K · 2025: $5,497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,125 · Food and Beverage: $5,977 · Travel and Lodging: $5,218 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Education: $21.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,125.00 |
| Food and Beverage | $5,976.75 |
| Travel and Lodging | $5,217.57 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Education | $21.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,811.75 | 2021-2025 | Esprit, Xact, Diamondback Coronary |
| Boston Scientific Corporation | $3,179.49 | 2020-2025 | Accolade Sr, Avvigo Guidance System, Watchman Flx |
| Actelion Pharmaceuticals US, INC. | $2,902.03 | 2019-2025 | Uptravi, Opsumit |
| Cardiovascular Systems INC. | $2,616.16 | 2020-2023 | Diamondback Peripheral, Diamondback Coronary |
| Abiomed | $1,927.58 | 2021-2025 | Impella |
| Janssen Pharmaceuticals, INC | $1,013.50 | 2019-2024 | Xarelto |
| Amgen INC. | $883.96 | 2019-2024 | Repatha |
| Medtronic, INC. | $583.41 | 2021-2025 | Symplicity G3, Hawkone, Abre |
| Shockwave Medical, INC | $456.93 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $327.11 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $312.65 | 2019-2023 | Brilinta |
| E.R. Squibb & Sons, L.L.C. | $298.87 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $293.37 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $286.87 | 2022-2025 | Winrevair |
| Bayer Healthcare Pharmaceuticals INC. | $253.50 | 2019-2024 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celonova Biosciences, INC. | $225.55 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $207.73 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $183.39 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $175.72 | 2021-2024 | Jardiance |
| Penumbra, INC. | $169.01 | 2025 | Indigo System |
| Recor Medical INC | $124.48 | 2024 | Paradise Renal Denervation System |
| Medtronic Vascular, INC. | $108.06 | 2019 | |
| Organogenesis INC. | $86.24 | 2020-2021 | |
| Smith+Nephew, INC. | $78.12 | 2021-2022 | |
| Getinge USA Sales, LLC | $67.81 | 2020 | |
| Novo Nordisk INC | $63.28 | 2024 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $61.56 | 2020-2021 | |
| Heartflow, INC. | $58.63 | 2024-2025 | |
| Lundbeck LLC | $56.57 | 2019-2021 | |
| Astellas Pharma US INC | $48.61 | 2019-2021 | |
| Esperion Therapeutics, INC. | $38.64 | 2020-2023 | Nexletol |
| Angiodynamics, INC. | $36.49 | 2025 | Auryon Laser System 100-120 Vac |
| Philips North America LLC | $33.71 | 2023 | |
| Portola Pharmaceuticals, LLC | $27.37 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $26.38 | 2023 | Inpefa |
| Cvrx, INC. | $25.66 | 2024 | Barostim Neo System |
| Cordis US Corp. | $24.16 | 2024 | Mynxgrip |
| Acist Medical Systems, INC. | $23.96 | 2023 | |
| Kiniksa Pharmaceuticals, LTD. | $21.14 | 2023 | Arcalyst |
| Surmodics, INC. | $15.68 | 2023 | Sublime Radial Access 018 Rx Pta Dilatation Catheter, Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| Bard Peripheral Vascular, INC. | $15.29 | 2019 | |
| Terumo Medical Corporation | $14.23 | 2019 | |
| Cardinal Health 200 LLC | $13.66 | 2019 | |
| Triad Life Sciences INC. | $13.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Yawn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.